Hashimoto’s disease affects an estimated 5% to 10% of the global population, making it one of the most common autoimmune disorders in the world. A 2022 meta-analysis in Frontiers in Public Health estimated the global adult prevalence at 7.5%. It is also the leading cause of hypothyroidism in countries with adequate iodine intake, meaning most people whose thyroid gland slows down have Hashimoto’s behind it.
How Many New Cases Occur Each Year
The annual incidence rate is roughly 3.5 new cases per 1,000 women and 0.8 per 1,000 men each year. To put that in perspective, in a group of 1,000 women followed for a year, about three or four will develop Hashimoto’s for the first time. Over a lifetime, those numbers accumulate quickly, which is why prevalence figures are so high.
Women Are Far More Likely To Be Affected
Hashimoto’s is overwhelmingly more common in women. The female-to-male ratio is at least 7 to 1, and some estimates put it closer to 10 to 1. The condition can appear at any age, but diagnoses peak between ages 45 and 55. Hormonal shifts around perimenopause and menopause may play a role in that timing, though genetics and immune system changes also contribute.
Children and adolescents can develop Hashimoto’s too, though it’s less common. Prevalence in children is estimated at 1.2% to 3%, and girls are affected two to four times more often than boys.
Racial and Ethnic Differences
Hashimoto’s does not affect all racial groups equally. Based on thyroid antibody data and confirmed by a large study of U.S. military personnel published in JAMA, rates of Hashimoto’s are highest in white populations and lowest in Black populations. Hispanic, Asian/Pacific Islander, and American Indian groups fall somewhere in between. These differences likely reflect a combination of genetic susceptibility and environmental factors rather than any single cause.
Family History Raises Your Risk
Genetics play a significant role. If you have a first-degree relative (parent, sibling, or child) with Hashimoto’s, your risk is meaningfully higher. A large genealogical study published in The Journal of Clinical Endocrinology and Metabolism found that first-degree relatives of people with Hashimoto’s had 1.77 times the odds of developing it themselves, with an absolute prevalence of 7.3% compared to 4.3% in the general population.
The risk is not distributed evenly within families. Daughters of an affected parent had about three times the odds of developing Hashimoto’s. Female siblings of someone with the condition had roughly 2.4 times the odds. Earlier research has estimated that first-degree relatives face anywhere from 4.5 to 32 times the risk depending on the population studied, though more recent, larger datasets suggest the increase is real but more modest than those upper estimates.
Many Cases Go Undiagnosed
One reason Hashimoto’s prevalence is hard to pin down is that many people have it without knowing. The condition develops slowly, sometimes over years, and early symptoms like fatigue or mild weight gain are easy to attribute to stress or aging. Population-based studies, which screen people regardless of whether they’ve sought medical care, find a prevalence of about 7.2%. Clinical studies, which look at people who’ve already shown up at a doctor’s office, find a slightly higher rate of 8.6%. That gap suggests a meaningful number of people in the general population have the condition but haven’t been diagnosed.
Adding to the complexity, between 10% and 19% of people without any thyroid disease test positive for thyroid antibodies, the same immune markers used to help diagnose Hashimoto’s. One study found that 43% of subjects with no personal or family history of thyroid problems had positive antibody levels. A positive antibody test doesn’t automatically mean you have or will develop Hashimoto’s, but it does indicate your immune system is reacting to thyroid tissue. Some of these people will go on to develop full-blown disease over time, while others never will.
Why It’s Considered Underrecognized
Hashimoto’s sits in an unusual spot: it’s extremely common by the numbers, yet many people have never heard of it before their own diagnosis. Part of the reason is that doctors often diagnose and treat the consequence (hypothyroidism, or low thyroid function) without necessarily testing for the underlying autoimmune cause. You might be told your thyroid is underactive and given medication without ever learning that Hashimoto’s is driving the problem. The condition also lacks the dramatic onset of some autoimmune diseases. It typically creeps in with nonspecific symptoms like brain fog, dry skin, sensitivity to cold, and sluggishness, none of which scream “autoimmune disease” to most people.
The practical takeaway is that Hashimoto’s is not rare or unusual. It affects roughly 1 in 13 to 1 in 20 adults worldwide, with significantly higher rates in women, older adults, white populations, and people with a family history of thyroid or autoimmune conditions. If you’re in one or more of those groups and experiencing symptoms of an underactive thyroid, the odds that Hashimoto’s is the explanation are substantial.